IKT earnings: a negative outcome, -6.3%

On August 16, 2021, Inhibikase Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.3% in the window around the event. It had already run -21.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.